Christopher Rhodes to Prognosis
This is a "connection" page, showing publications Christopher Rhodes has written about Prognosis.
Connection Strength
0.369
-
Using the Plasma Proteome for Risk Stratifying Patients with Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2022 05 01; 205(9):1102-1111.
Score: 0.122
-
Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial Hypertension. Circulation. 2017 01 31; 135(5):460-475.
Score: 0.084
-
Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension. Heart. 2011 Jul; 97(13):1054-60.
Score: 0.057
-
Cytokines as prognostic biomarkers in pulmonary arterial hypertension. Eur Respir J. 2023 03; 61(3).
Score: 0.033
-
Immunoglobulin-driven Complement Activation Regulates Proinflammatory Remodeling in Pulmonary Hypertension. Am J Respir Crit Care Med. 2020 01 15; 201(2):224-239.
Score: 0.026
-
Reduced plasma levels of small HDL particles transporting fibrinolytic proteins in pulmonary arterial hypertension. Thorax. 2019 04; 74(4):380-389.
Score: 0.024
-
Identification of rare sequence variation underlying heritable pulmonary arterial hypertension. Nat Commun. 2018 04 12; 9(1):1416.
Score: 0.023